Jii Bum Lee

958 total citations
47 papers, 545 citations indexed

About

Jii Bum Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jii Bum Lee has authored 47 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Jii Bum Lee's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Jii Bum Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Jii Bum Lee collaborates with scholars based in South Korea, United States and Singapore. Jii Bum Lee's co-authors include Hye Ryun Kim, Sang‐Jun Ha, Kyoung‐Ho Pyo, Joong Bae Ahn, Byoung Chul Cho, Han Sang Kim, Sun Min Lim, Hyun Cheol Chung, Sun Young Rha and Sang Joon Shin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jii Bum Lee

40 papers receiving 536 citations

Peers

Jii Bum Lee
Runzhe Chen China
Antonio Cusmai Italy
Miso Kim South Korea
Daniel Vilarim Araújo Canada
Shannon Zhang United States
Andrew Cannon United States
Roberto Borea Italy
Gesa Schuebbe Germany
M. Durante United States
Yaewon Yang South Korea
Runzhe Chen China
Jii Bum Lee
Citations per year, relative to Jii Bum Lee Jii Bum Lee (= 1×) peers Runzhe Chen

Countries citing papers authored by Jii Bum Lee

Since Specialization
Citations

This map shows the geographic impact of Jii Bum Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jii Bum Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jii Bum Lee more than expected).

Fields of papers citing papers by Jii Bum Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jii Bum Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jii Bum Lee. The network helps show where Jii Bum Lee may publish in the future.

Co-authorship network of co-authors of Jii Bum Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jii Bum Lee. A scholar is included among the top collaborators of Jii Bum Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jii Bum Lee. Jii Bum Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jii Bum, et al.. (2025). Evolving roles of MET as a therapeutic target in NSCLC and beyond. Nature Reviews Clinical Oncology. 22(9). 640–666. 1 indexed citations
2.
Kwon, Kee Woong, Jii Bum Lee, Su Jin Jeong, et al.. (2025). Mycobacterium tuberculosis-specific T cells restrain anti-cancer drug-induced neutrophilic lung inflammation in tuberculosis. Nature Communications. 16(1). 8875–8875. 2 indexed citations
3.
Lee, Jii Bum, et al.. (2024). Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities. Lung Cancer. 194. 107862–107862. 3 indexed citations
4.
Lim, Sun Min, et al.. (2024). Real-world outcomes with lurbinectedin in second-line and beyond for small cell lung cancer in Korea.. Journal of Clinical Oncology. 42(23_suppl). 211–211.
5.
6.
Lee, You Won, Jii Bum Lee, Min Hee Hong, et al.. (2024). Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical Cancer Research. 30(8). 1582–1594. 10 indexed citations
7.
Kim, Mi H., Min Hee Hong, Jii Bum Lee, et al.. (2024). A Comprehensive Analysis of HLA-A and HLA-DR Allele Frequencies and Haplotype Associations in a Korean Population of 790 Individuals. SHILAP Revista de lepidopterología. 56(3). 236–247. 1 indexed citations
8.
Lee, Jii Bum, Hyo Sup Shim, Chang Young Lee, et al.. (2024). Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA). Journal of Thoracic Oncology. 20(5). 641–650. 2 indexed citations
9.
Lee, Jii Bum & Sai‐Hong Ignatius Ou. (2024). ATTLAS, IMpower151 and ORIENT-31: Dusting off IMpower150 for Post-Osimertinib in EGFR-Mutated NSCLC?. PubMed. Volume 15. 81–85. 2 indexed citations
10.
Lee, Choong‐kun, Jii Bum Lee, Se Jin Park, et al.. (2023). Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study. Gastric Cancer. 27(1). 118–130. 10 indexed citations
11.
Lim, Sun Min, et al.. (2023). Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations. Therapeutic Advances in Medical Oncology. 15. 4287558163–4287558163. 13 indexed citations
12.
Yu, Mi Ra, Mi Ran Yun, Jii Bum Lee, et al.. (2023). Abstract 4029: JIN-A04, highly effective tyrosine kinase inhibitor targeting HER2 exon 20 insertion mutations in NSCLC. Cancer Research. 83(7_Supplement). 4029–4029. 1 indexed citations
13.
Kim, Hyunwook, Beung‐Chul Ahn, Jiyun Lee, et al.. (2023). Lazertinib in Pretreated EGFR T790M-Mutated Advanced Non-Small Cell Lung Cancer: A Real-World Multicenter Study. SSRN Electronic Journal.
14.
Ahn, Beung‐Chul, Seo-Young Lee, Jiyun Lee, et al.. (2023). Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea. Cancer Treatment and Research Communications. 36. 100715–100715. 1 indexed citations
15.
Jung, Minkyu, Jii Bum Lee, Hyo Song Kim, et al.. (2023). First-in-Human Phase 1 Study of a B Cell– and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric Cancer. Cancer Research and Treatment. 56(1). 208–218. 10 indexed citations
16.
Lee, Jii Bum, Hyung Soon Park, Su Jin Choi, et al.. (2022). Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. Therapeutic Advances in Medical Oncology. 14. 4287553793–4287553793. 3 indexed citations
17.
Lee, Jii Bum, Sang‐Jun Ha, & Hye Ryun Kim. (2021). Clinical Insights Into Novel Immune Checkpoint Inhibitors. Frontiers in Pharmacology. 12. 681320–681320. 82 indexed citations
18.
19.
Kim, Yundeok, Tae‐Hwa Go, Jii Bum Lee, et al.. (2021). Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia. The Korean Journal of Internal Medicine. 36(6). 1450–1458. 10 indexed citations
20.
Kang, Eun Joo, Yun‐Gyoo Lee, Bhumsuk Keam, et al.. (2021). Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01). The Korean Journal of Internal Medicine. 37(1). 190–200. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Runzhe Chen Breakdown of academic impact, for papers by Antonio Cusmai Breakdown of academic impact, for papers by Miso Kim Breakdown of academic impact, for papers by Daniel Vilarim Araújo Breakdown of academic impact, for papers by Shannon Zhang Breakdown of academic impact, for papers by Andrew Cannon Breakdown of academic impact, for papers by Roberto Borea Breakdown of academic impact, for papers by Gesa Schuebbe Breakdown of academic impact, for papers by M. Durante Breakdown of academic impact, for papers by Yaewon Yang
Rankless by CCL
2026